HIGHLIGHTS
- who: Steffen Spoerl et al. from the Department of Cranio-Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany have published the paper: Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study, in the Journal: (JOURNAL) of 31/Dec/2017
- what: The aim of this population-based multicenter cohort study was to evaluate the prognostic roles of DM2 and metformin in primarily resected HNM patients.
SUMMARY
Due to its worldwide prevalence of around 400 million people, diabetes represents a major challenge . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.